Reversed-phase high-performance liquid chromatographic study of thimerosal stability in Cuban recombinant hepatitis B vaccine

Journal of Chromatography A

Volumn 729, Issue 1-2, 1996, Pages 219-227

  Tleugabulova, Dina ^a   González Pérez, Idania ^b  

^a National Center for Bioproducts   (Cuba)

^b CENTER FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Cuba)

Author keywords

Salicylic acid; Thimerosal; Thiosalicylic acids; Vaccines

Indexed keywords

RECOMBINANT HEPATITIS B VACCINE; THIOMERSAL;

CALIBRATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG DETERMINATION; DRUG MIXTURE; DRUG STABILITY; NONHUMAN; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; TECHNIQUE;

EID: 0343867254     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9673(95)00993-0     Document Type: Conference Paper

References (28)

1. M.J. Reader and C.B. Lines, J. Pharm. Sci., 72 (1983) 1406.
2. A.M. Rabasco and I. Caraballo, presented at the VIII Jornadas Farmaceuticas Españolas, Seville, 3-6 December, 1991.
3. N.E. Richardson, D.J. Davies, B.J. Meakin and D.A. Norton, J. Pharm. Pharmacol., 29 (1977) 717.
4. D.S. Bushee, Analyst, 113 (1988) 1167.
5. W. Holak, J. Liq. Chromatogr., 8 (1985) 563.
6. W. Holak, Analyst, 107 (1982) 1457.
7. Y.S. Krull, D.S. Bushee, R.S. Schleicher and S.B. Smith, Analyst, 111 (1986) 345.
8. W.A. MacCrehan, R.A. Durst and J.M. Bellama, Anal. Lett., 10 (1977) 1175.
9. O. Evans and G.D. McKee, Analyst, 112 (1987) 983.
10. O. Evans and G.D. McKee, Analyst, 113 (1988) 243.
11. W. Langseth, Anal. Chim. Acta, 185 (1986) 249.
12. S. Inoue, S. Hoshi and M. Mathubara, Talanta, 32 (1985) 44.
13. J.E. Parkin, J. Chromatogr., 407 (1987) 389.
14. J.E. Parkin, J. Chromatogr., 472 (1989) 401.
15. W. Langseth, J. Chromatogr., 438 (1988) 414.
16. J.E. Parkin, J. Chromatogr., 542 (1991) 137.
17. Y.-C. Wang and C.-W. Wang, J. Chromatogr., 628 (1993) 133.
18. C.G. Visor, R.A. Kenley, J.S. Fleitman, D.A. Neu and Y.W. Partridge, Pharm. Res., 2 (1985) 73.
19. K. Thoma and O.E. Shubert, Dtsch. Apoth.-Ztg., 127 (1987) 1867.
20. J.S. Fleitman and Y.W. Partridge, Drug Dev. Ind. Pharm., 17 (1991) 519.
21. M.J. Reader, J. Pharm. Sci., 73 (1984) 840.
22. A.M. Rabasco, I. Caraballo and M. Fernández-Arévalo, Drug Dev. Ind. Pharm., 19 (1993) 1673.
23. I. Caraballo, A.M. Rabasco and M. Fernández-Arévalo, Int. J. Pharm., 89 (1993) 213.
24. Norma Cubana 26-206:1991. Medicamentos. Vacuna Anti-Hepatitis B de Antígeno de Superficie Viral ADN Recombinante. Especificaciones.
25. N.E. Richardson, DJ. Davies, B.J. Meakin and D.A. Norton, J. Pharm. Pharmacol., 30 (1978) 469.
26. Cs. Horváth, W. Melander and A. Nahum, J. Chromatogr., 186 (1979) 371.
27. S.L. Hem and J.L. White, J. Parent. Sci. Technol., 38 (1984) 2.
28. R.J. Sepelyak, J.R. Feldkamp, T.E. Moody, J.L. White and S.L. Hem, J. Pharm. Sci., 73 (1984) 1514.